ADCY8 and breast cancer: In triple-negative MDA-MB-231 breast cancer cells of the MSL subtype [75], both Orai1 variants as well as AC8 show an enhanced expression at the protein level, but these cells predominantly express AC8, which shifts the Orai1α/AC8 stoichiometry in favor of AC8 [63].